Joseph Shulman's Stock Transactions in Rhythm Pharmaceuticals, Inc.

Joseph Shulman, an officer at Rhythm Pharmaceuticals, Inc., has reported significant stock transactions. On October 16, 2025, Shulman exercised stock options to acquire 14,437 common shares. Additionally, Shulman sold a total of 24,953 common shares in the past three months, with the most substantial sale occurring on September 2, 2025, where 16,781 shares were sold for $1,767,005.62. These transactions were conducted under a 10b5-1 trading plan, which allows company insiders to sell shares at predetermined times to avoid accusations of insider trading. The aggregate market value of the shares sold in the past three months amounts to $2,544,987.95. These transactions highlight significant insider activity in Rhythm Pharmaceuticals, Inc.